- Home
- SXTP vs SNES Comparison
SXTP vs SNES Comparison
Compare SXTP & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- SNES
- Stock Information
- Founded
- SXTP 2010
- SNES 2004
- Country
- SXTP United States
- SNES United States
- Employees
- SXTP N/A
- SNES N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- SNES Agricultural Chemicals
- Sector
- SXTP Health Care
- SNES Industrials
- Exchange
- SXTP Nasdaq
- SNES Nasdaq
- Market Cap
- SXTP 2.7M
- SNES 2.3M
- IPO Year
- SXTP 2023
- SNES 2016
- Fundamental
- Price
- SXTP $0.83
- SNES $2.80
- Analyst Decision
- SXTP Hold
- SNES Strong Buy
- Analyst Count
- SXTP 1
- SNES 1
- Target Price
- SXTP N/A
- SNES $10.00
- AVG Volume (30 Days)
- SXTP 967.9K
- SNES 50.7K
- Earning Date
- SXTP 11-14-2024
- SNES 02-19-2025
- Dividend Yield
- SXTP N/A
- SNES N/A
- EPS Growth
- SXTP N/A
- SNES N/A
- EPS
- SXTP N/A
- SNES N/A
- Revenue
- SXTP $462,612.00
- SNES $1,651,000.00
- Revenue This Year
- SXTP $141.35
- SNES $76.36
- Revenue Next Year
- SXTP $175.16
- SNES $103.47
- P/E Ratio
- SXTP N/A
- SNES N/A
- Revenue Growth
- SXTP 128.99
- SNES 38.16
- 52 Week Low
- SXTP $0.70
- SNES $1.90
- 52 Week High
- SXTP $10.67
- SNES $13.30
- Technical
- Relative Strength Index (RSI)
- SXTP 36.41
- SNES 44.04
- Support Level
- SXTP $0.87
- SNES $2.97
- Resistance Level
- SXTP $0.95
- SNES $3.20
- Average True Range (ATR)
- SXTP 0.14
- SNES 0.29
- MACD
- SXTP -0.06
- SNES -0.07
- Stochastic Oscillator
- SXTP 6.99
- SNES 9.99
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.